
Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer
A new machine learning model can pinpoint the origin of mysterious cancers from simple blood fragments, shifting the focus of liquid biopsies from detection to direction.








